New OTC Nexium approved

Share this article:

Pfizer's consumer portfolio now includes a 24-hour version of over-the-counter Nexium. The company announced Friday that the FDA greenlighted the no-prescription heartburn medication.

The company is also pursuing an OTC version of its former prescription blockbuster cholesterol medication Lipitor.

Pfizer acquired worldwide marketing rights to the non-Rx version of AZ's blockbuster proton-pump inhibitor in 2012. Deal terms called for a $250-million upfront payment.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Illumina inks deal with J&J, AstraZeneca, Sanofi

The goal is to develop companion diagnostics to match patients with cancer treatments.

Abbott deal highlights inversion inaction

Political furor over the recent spate of tax inversions is having little influence on how the government chooses its partners.

Allergan reported to seek out Salix deal

The Wall Street Journal says the deal would add "another layer of intrigue" to the Allergan-Valeant hostilities.